Nanox Imaging Ltd. (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement positions Nanox to enter its third Latin American market this year, following Argentina and Peru, signaling the company's accelerating expansion into regions where advanced imaging technology is often scarce.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. This relationship could facilitate adoption of the Nanox.ARC within Costa Rica's public healthcare system, potentially improving access to advanced medical imaging for a broad population. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This phased approach allows for clinical validation and demonstration of the system's benefits before full-scale deployment.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. It is part of the broader Nanox ecosystem, which includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The company's vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. This agreement with SOLME RC is a concrete step toward realizing that vision in Costa Rica, where access to advanced imaging may be limited.
The move into Costa Rica is part of Nanox's strategy to drive the world's transition to preventive health care. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes. The agreement could serve as a model for other markets in the region, demonstrating the viability of Nanox's integrated solution in diverse healthcare environments.
For investors, the agreement represents progress in Nanox's commercialization efforts and potential revenue growth. The latest news and updates relating to NNOX are available in the company's newsroom at http://ibn.fm/NNOX. To view the full press release, visit https://ibn.fm/C77lJ. As Nanox continues to expand its global footprint, the Costa Rica agreement underscores its commitment to making advanced medical imaging more accessible and could pave the way for similar agreements in other underserved regions.
